512 related articles for article (PubMed ID: 19250146)
1. Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
Adan-Manes J; Garcia-Parajua P
J Clin Pharm Ther; 2009 Apr; 34(2):245-6. PubMed ID: 19250146
[TBL] [Abstract][Full Text] [Related]
2. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
Lu ML; Shen WW; Chen CH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
[TBL] [Abstract][Full Text] [Related]
3. [A new pharmacological strategy for schizophrenia: the partial agonists of D2 dopaminergic receptors. The principle characteristics of aripiprazole].
Costentin J
Encephale; 2009 Feb; 35(1):66-72. PubMed ID: 19250996
[TBL] [Abstract][Full Text] [Related]
4. Benefits of combining aripiprazole to clozapine: three case reports.
Rocha FL; Hara C
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1167-9. PubMed ID: 16647796
[TBL] [Abstract][Full Text] [Related]
5. [Aripiprazole induced Parkinsonism: A case report].
Pasquier de Franclieu S; Germain C; Petitjean F
Encephale; 2009 Oct; 35(5):496-8. PubMed ID: 19853725
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia.
Saitis M; Papazisis G; Katsigiannopoulos K; Kouvelas D
Psychiatry Clin Neurosci; 2008 Oct; 62(5):624. PubMed ID: 18950388
[No Abstract] [Full Text] [Related]
7. Aripiprazole-associated dyskinesia.
Sajbel TA; Cheney EM; DeQuardo JR
Ann Pharmacother; 2005 Jan; 39(1):200-1. PubMed ID: 15598969
[No Abstract] [Full Text] [Related]
8. [A new approach to antischizophrenic therapeutics: D2 dopamine receptor partial agonists].
Costentin J
Ann Pharm Fr; 2009 Sep; 67(5):310-9. PubMed ID: 19695367
[TBL] [Abstract][Full Text] [Related]
9. Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
Rajarethinam R; Dziuba J; Manji S; Pizzuti A; Lachover L; Keshavan M
World J Biol Psychiatry; 2009; 10(4 Pt 2):416-9. PubMed ID: 19492247
[TBL] [Abstract][Full Text] [Related]
10. [Aripiprazole: a new atypical antipsychotic drug].
Fischer B; Davids E; Gastpar M
Fortschr Neurol Psychiatr; 2004 Sep; 72(9):497-502. PubMed ID: 15365912
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
[TBL] [Abstract][Full Text] [Related]
12. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
[TBL] [Abstract][Full Text] [Related]
13. Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia.
Gründer G; Kungel M; Ebrecht M; Göröcs T; Modell S
Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S21-5. PubMed ID: 16508892
[TBL] [Abstract][Full Text] [Related]
14. Agitation associated with aripiprazole initiation.
Lea JW; Stoner SC; Lafollette J
Pharmacotherapy; 2007 Sep; 27(9):1339-42. PubMed ID: 17723088
[TBL] [Abstract][Full Text] [Related]
15. Worsening of psychosis in a 30 year old man with undifferentiated schizophrenia.
Ahuja N; Lloyd AJ
Ann Clin Psychiatry; 2008; 20(2):113-4. PubMed ID: 18568584
[No Abstract] [Full Text] [Related]
16. Is aripiprazole the only choice of treatment of the patients who developed anti-psychotic agents-induced leucopenia and neutropenia? A case report.
Yalcin DO; Goka E; Aydemir MC; Kisa C
J Psychopharmacol; 2008 May; 22(3):333-5. PubMed ID: 18208928
[TBL] [Abstract][Full Text] [Related]
17. A case of aripiprazole and tardive dyskinesia.
Abbasian C; Power P
J Psychopharmacol; 2009 Mar; 23(2):214-5. PubMed ID: 18515468
[TBL] [Abstract][Full Text] [Related]
18. Tardive dyskinesia in a patient treated with quetiapine.
Rizos E; Douzenis A; Gournellis R; Christodoulou C; Lykouras LP
World J Biol Psychiatry; 2009; 10(1):54-7. PubMed ID: 19673087
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole in the treatment of Alzheimer's disease.
De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
[TBL] [Abstract][Full Text] [Related]
20. The effect of aripiprazole and quinagolide, a dopamine agonist, in a patient with symptomatic pituitary prolactinoma and chronic psychosis.
Broekhof R; Gosselink MJ; Pijl H; Giltay EJ
Gen Hosp Psychiatry; 2012; 34(2):209.e1-3. PubMed ID: 21872335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]